ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 40 filers reported holding ALLENA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 2.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $30,000 | -74.4% | 23,339 | -70.4% | 0.00% | – |
| Q3 2020 | $117,000 | +165.9% | 78,934 | +180.8% | 0.00% | – |
| Q2 2020 | $44,000 | -52.2% | 28,112 | -16.8% | 0.00% | – |
| Q4 2019 | $92,000 | -71.9% | 33,784 | -59.3% | 0.00% | – |
| Q3 2019 | $327,000 | +16.0% | 83,016 | +19.8% | 0.00% | – |
| Q2 2019 | $282,000 | +261.5% | 69,308 | +522.3% | 0.00% | – |
| Q1 2019 | $78,000 | -67.2% | 11,137 | -49.8% | 0.00% | – |
| Q3 2018 | $238,000 | -20.1% | 22,177 | -3.2% | 0.00% | – |
| Q2 2018 | $298,000 | -7.5% | 22,904 | -21.6% | 0.00% | – |
| Q1 2018 | $322,000 | -35.5% | 29,207 | -41.2% | 0.00% | – |
| Q4 2017 | $499,000 | – | 49,643 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 2,263,365 | $20,493,000 | 82.81% |
| Pharmstandard International S.A. | 1,037,267 | $10,435,000 | 10.73% |
| Partner Investment Management, L.P. | 575,407 | $4,724,000 | 5.44% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $33,504,000 | 5.43% |
| TRV GP II, LLC | 2,790,964 | $28,077,000 | 5.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 325,000 | $3,270,000 | 0.38% |
| PFM Health Sciences, LP | 1,464,204 | $13,255,000 | 0.31% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 605,100 | $6,087,000 | 0.24% |
| Perceptive Advisors | 250,000 | $2,515,000 | 0.08% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 18,288 | $259,000 | 0.07% |